πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,742 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9512204

Humanized pertussis antibodies and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9511152

Multicolored pH-activatable fluorescence nanoplatform

The Board of Regents of the University of Texas System Β· Granted Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9504658

Stabilized HME composition with small drug particles

The Board of Regents of the University of Texas System Β· Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9504701

Methods for treating viral infections using hydrogen sulfide donors

The Board of Regents of the University of Texas System Β· Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9504742

Compositions for stimulation of mammalian innate immune resistance to pathogens

The Board of Regents of the University of Texas System Β· Granted Tue Nov 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9499595

Development of influenza A antivirals

The Board of Regents of the University of Texas System Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9499588

Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereo

The Board of Regents of the University of Texas System Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9502711

Fabrication of biscrolled fiber using carbon nanotube sheet

The Board of Regents of the University of Texas System Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9492477

Compositions comprising citrate and applications thereof

The Board of Regents of the University of Texas System Β· Granted Tue Nov 15 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9486456

Treatment of esophageal motility disorder using sepiapterin, tetrahydrobiopterin and deriv

The Board of Regents of the University of Texas System Β· Granted Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9481692

Heterocyclic modulators of HIF activity for treatment of disease

The Board of Regents of the University of Texas System Β· Granted Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9481877

Engineered primate L-methioninase for therapeutic purposes

The Board of Regents of the University of Texas System Β· Granted Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9474730

Methods and compositions for use with K-ras mediated disorders

The Board of Regents of the University of Texas System Β· Granted Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 20 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9469878

Methods of treating cancer comprising targeting NQO1

The Board of Regents of the University of Texas System Β· Granted Tue Oct 18 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9463254

Molecular design toward dual-modality probes for radioisotope-based imaging (PET or SPECT)

The Board of Regents of the University of Texas System Β· Granted Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9457002

Antimicrobial compositions comprising glyceryl nitrates

The Board of Regents of the University of Texas System Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9458095

Oligo-benzamide compounds and their use in treating cancers

The Board of Regents of the University of Texas System Β· Granted Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9452182

Collateral gene inactivation biomarkers and targets for cancer therapy

The Board of Regents of the University of Texas System Β· Granted Tue Sep 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9446042

Pro-neurogenic compounds

The Board of Regents of the University of Texas System Β· Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9447047

Inhibitors of protein phosphatase-1 and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9446022

Pro-neurogenic compounds

The Board of Regents of the University of Texas System Β· Granted Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9439976

Compositions and methods for using cathepsin E cleavable substrates

The Board of Regents of the University of Texas System Β· Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9428749

Control of whole body energy homeostasis by microRNA regulation

The Board of Regents of the University of Texas System Β· Granted Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9422529

Alphavirus compositions and methods of use

The Board of Regents of the University of Texas System Β· Granted Tue Aug 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted